⌘K

Login Start Free

Home/Filings/4/A/0001567619-23-000303

4/A//SEC Filing

Yorke Justin W 4/A

Accession 0001567619-23-000303

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 5:29 PM ET

Size

5.6 KB

Accession

0001567619-23-000303

Insider Transaction Report

Form 4/AAmended

Period: 2022-08-05

Processa Pharmaceuticals, Inc.PCSA

Director

Transactions

Exercise/Conversion
Common Stock
2022-08-05+1,169→ 14,885 total

Holdings

Common Stock
(indirect: By LLC)
532,563

Footnotes (2)

[F1]Vesting of time-based restricted shares.
[F2]Previous filing inadvertently underreported shares beneficially owned by the reporting person.

Documents

1 file

4
doc1.xml
FORM 4/A

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001361896

Filing Metadata

Form type: 4/A
Filed: Jan 3, 7:00 PM ET
Accepted: Jan 4, 5:29 PM ET
Size: 5.6 KB

View on SEC.gov